Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
XBiotech (DE:4XB)
FRANKFURT:4XB
XBiotech (4XB) Stock Price & Analysis
0 Followers
4XB Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€2.72 - €9.05
Previous Close€8.3
Volume0.00
Average Volume (3M)56.00
Market Cap
€231.33M
Enterprise Value€42.92M
Total Cash (Recent Filing)$200.02M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)N/A
Beta0.78
Next Earnings
May 09, 2019EPS EstimateN/A
Last Dividend Ex-Date
Jul 15, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding30,450,881
10 Day Avg. Volume5
30 Day Avg. Volume56
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)1.25
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-19.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.29
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
XBiotech News
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
0.04% Other Institutional Investors
99.96% Public Companies and
Individual Investors
4XB FAQ
What was XBiotech’s price range in the past 12 months?
XBiotech lowest stock price was €2.72 and its highest was €9.05 in the past 12 months.
What is XBiotech’s market cap?
Currently, no data Available
When is XBiotech’s upcoming earnings report date?
XBiotech’s upcoming earnings report date is May 09, 2019 which is 1807 days ago.
How were XBiotech’s earnings last quarter?
XBiotech released its earnings results on Mar 14, 2019. The company reported -€0.16 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.16.
Is XBiotech overvalued?
According to Wall Street analysts XBiotech’s price is currently Overvalued.
Does XBiotech pay dividends?
XBiotech pays a Notavailable dividend of €2.35 which represents an annual dividend yield of N/A. See more information on XBiotech dividends here
What is XBiotech’s EPS estimate?
XBiotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does XBiotech have?
Currently, no data Available
What happened to XBiotech’s price movement after its last earnings report?
XBiotech reported an EPS of -€0.16 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of XBiotech?
Among the largest hedge funds holding XBiotech’s share is Caxton Associates LP. It holds XBiotech’s shares valued at N/A.
---
XBiotech Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
120.38%
12-Months-Change
Fundamentals
Return on Equity
-10.69%
Trailing 12-Months
Asset Growth
-8.28%
Trailing 12-Months
Company Description
XBiotech
XBiotech, Inc. is a biopharmaceutical company, which engages in development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
---
Technical Analysis
---